Virtus LifeSci Biotech Products ETF (BBP) Holdings
BBP holdings summary
as of Oct 25, 2026- Holdings
- 65 positions listed
- Top 10 weight
- 27.5% of net assets
- Effective holdings
- 52 equal-weight equivalent
- Largest holding
- MRNA 5.46% Moderna, Inc.
- Annual turnover
- 48.3% of the portfolio traded
All BBP holdings
| # | Name | ||||||
|---|---|---|---|---|---|---|---|
| 1 | MRNA | Moderna, Inc. | Healthcare | 5.46% | $7.1M | $87.04B | — |
| 2 | IOVA | Iovance Biotherapeutics, Inc. | Healthcare | 4.47% | $5.8M | $6.17B | — |
| 3 | VSTM | Verastem, Inc. | Healthcare | 3.16% | $4.1M | $783.4M | — |
| 4 | HALO | Halozyme Therapeutics, Inc. | Healthcare | 2.40% | $3.1M | $13.83B | 35.6 |
| 5 | OMER | Omeros Corporation | Healthcare | 2.40% | $3.1M | $1.17B | 13.3 |
| 6 | RIGL | Rigel Pharmaceuticals, Inc. | Healthcare | 1.99% | $2.6M | $858.7M | 2.7 |
| 7 | ONC | BeiGene, Ltd. | Healthcare | 1.96% | $2.5M | $41.99B | 66.0 |
| 8 | KNSA | Kiniksa Pharmaceuticals, Ltd. | Healthcare | 1.91% | $2.5M | $6.13B | 79.4 |
| 9 | XERS | Xeris Biopharma Holdings, Inc. | Healthcare | 1.89% | $2.5M | $1.88B | — |
| 10 | PGEN | Precigen, Inc. | Healthcare | 1.86% | $2.4M | $2.28B | — |
| 11 | ZLAB | Zai Lab Limited | Healthcare | 1.84% | $2.4M | $2.60B | — |
| 12 | REGN | Regeneron Pharmaceuticals, Inc. | Healthcare | 1.75% | $2.3M | $81.41B | 19.6 |
| 13 | PTGX | Protagonist Therapeutics, Inc. | Healthcare | 1.72% | $2.2M | $8.33B | 125.0 |
| 14 | ADMA | ADMA Biologics, Inc. | Healthcare | 1.71% | $2.2M | $2.39B | 15.3 |
| 15 | BIIB | Biogen Inc. | Healthcare | 1.68% | $2.2M | $34.37B | 41.3 |
| 16 | ZA8 | ZYMEWORKS DL-00001 | Healthcare | 1.67% | $2.2M | — | — |
| 17 | ARQT | Arcutis Biotherapeutics, Inc. | Healthcare | 1.67% | $2.2M | $3.62B | 131.0 |
| 18 | LGND | Ligand Pharmaceuticals Incorporated | Healthcare | 1.62% | $2.1M | $5.89B | 31.1 |
| 19 | GILD | Gilead Sciences, Inc. | Healthcare | 1.61% | $2.1M | $193.67B | — |
| 20 | AGIO | Agios Pharmaceuticals, Inc. | Healthcare | 1.61% | $2.1M | $1.87B | — |
| 21 | EXEL | Exelixis, Inc. | Healthcare | 1.59% | $2.1M | $15.42B | 19.6 |
| 22 | VRTX | Vertex Pharmaceuticals Incorporated | Healthcare | 1.57% | $2.0M | $126.66B | 28.9 |
| 23 | AMGN | Amgen Inc. | Healthcare | 1.56% | $2.0M | $233.82B | 26.9 |
| 24 | ROIV | Roivant Sciences Ltd. | Healthcare | 1.54% | $2.0M | $24.22B | — |
| 25 | SRPT | Sarepta Therapeutics, Inc. | Healthcare | 1.51% | $2.0M | $1.81B | — |
| 26 | NK | NantKwest Inc | Healthcare | 1.51% | $2.0M | — | — |
| 27 | NVAX | Novavax, Inc. | Healthcare | 1.49% | $1.9M | $1.86B | — |
| 28 | KURA | Kura Oncology, Inc. | Healthcare | 1.46% | $1.9M | $807.8M | — |
| 29 | ASND | Ascendis Pharma A/S | Healthcare | 1.42% | $1.8M | $14.82B | 17.3 |
| 30 | TARS | Tarsus Pharmaceuticals, Inc. | Healthcare | 1.41% | $1.8M | $3.19B | — |
| 31 | AUP | Aurinia Pharmaceuticals Inc | Technology | 1.40% | $1.8M | — | — |
| 32 | BBIO | BridgeBio Pharma, Inc. | Healthcare | 1.39% | $1.8M | $12.98B | — |
| 33 | IMCR | Immunocore Holdings plc | Healthcare | 1.39% | $1.8M | $1.51B | — |
| 34 | INCY | Incyte Corporation | Healthcare | 1.38% | $1.8M | $22.92B | 14.4 |
| 35 | UTHR | United Therapeutics Corporation | Healthcare | 1.38% | $1.8M | $22.87B | 19.1 |
| 36 | TGTX | TG Therapeutics, Inc. | Healthcare | 1.37% | $1.8M | $8.26B | 19.6 |
| 37 | BMRN | BioMarin Pharmaceutical Inc. | Healthcare | 1.34% | $1.7M | $10.58B | 147.8 |
| 38 | HRMY | Harmony Biosciences Holdings, Inc. | Healthcare | 1.32% | $1.7M | $2.21B | 12.2 |
| 39 | INSM | Insmed Incorporated | Healthcare | 1.28% | $1.7M | $21.02B | — |
| 40 | CRSP | CRISPR Therapeutics AG | Healthcare | 1.28% | $1.7M | $4.76B | — |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | Healthcare | 1.27% | $1.6M | $5.91B | — |
| 42 | GERN | Geron Corporation | Healthcare | 1.27% | $1.6M | $751.7M | — |
| 43 | BNTX | BioNTech SE | Healthcare | 1.27% | $1.6M | $22.03B | — |
| 44 | TVTX | Travere Therapeutics, Inc. | Healthcare | 1.26% | $1.6M | $4.61B | — |
| 45 | KRYS | Krystal Biotech, Inc. | Healthcare | 1.25% | $1.6M | $9.37B | 39.7 |
| 46 | ACAD | ACADIA Pharmaceuticals Inc. | Healthcare | 1.25% | $1.6M | $3.29B | 8.6 |
| 47 | BCRX | BioCryst Pharmaceuticals, Inc. | Healthcare | 1.21% | $1.6M | $1.99B | — |
| 48 | IRWD | Ironwood Pharmaceuticals, Inc. | Healthcare | 1.21% | $1.6M | $578.3M | 4.5 |
| 49 | NUVB | Nuvation Bio Inc. | Healthcare | 1.19% | $1.5M | $1.56B | — |
| 50 | CYTK | Cytokinetics, Incorporated | Healthcare | 1.18% | $1.5M | $8.61B | — |
| 51 | MDGL | Madrigal Pharmaceuticals, Inc. | Healthcare | 1.15% | $1.5M | $10.39B | — |
| 52 | NBIX | Neurocrine Biosciences, Inc. | Healthcare | 1.13% | $1.5M | $13.79B | 19.9 |
| 53 | DNLI | Denali Therapeutics Inc. | Healthcare | 1.12% | $1.5M | $2.81B | — |
| 54 | PTCT | PTC Therapeutics, Inc. | Healthcare | 1.08% | $1.4M | $4.94B | — |
| 55 | ALNY | Alnylam Pharmaceuticals, Inc. | Healthcare | 1.07% | $1.4M | $31.02B | 39.1 |
| 56 | ARWR | Arrowhead Pharmaceuticals, Inc. | Healthcare | 1.05% | $1.4M | $7.90B | — |
| 57 | MIRM | Mirum Pharmaceuticals, Inc. | Healthcare | 1.05% | $1.4M | $5.20B | — |
| 58 | SNDX | Syndax Pharmaceuticals, Inc. | Healthcare | 0.92% | $1.2M | $1.15B | — |
| 59 | RARE | Ultragenyx Pharmaceutical Inc. | Healthcare | 0.82% | $1.1M | $1.43B | — |
| 60 | LQDA | Liquidia Corporation | Healthcare | 0.77% | $1.0M | $3.07B | 24.7 |
| 61 | AXSM | Axsome Therapeutics, Inc. | Healthcare | 0.77% | $1.0M | $8.23B | — |
| 62 | IONS | Ionis Pharmaceuticals, Inc. | Healthcare | 0.76% | $991,217.87 | $7.14B | — |
| 63 | ARDX | Ardelyx, Inc. | Healthcare | 0.73% | $952,389.87 | $797.8M | — |
| 64 | PHAT | Phathom Pharmaceuticals, Inc. | Healthcare | 0.71% | $916,288.91 | $559.8M | — |
| 65 | LEGN | Legend Biotech Corporation | Healthcare | 0.70% | $913,821.58 | $3.59B | — |
Weights as a percentage of net assets. Value held = weight × net assets ($129.9M). Market cap and P/E from each company's latest fundamentals (U.S.-listed stocks).
BBP sector breakdown
Sum of the weights of the holdings in each sector.
BBP top industries
BBP overlap with other ETFs
| ETF | Fund | Overlap | Shared holdings | Expense ratio |
|---|---|---|---|---|
| IWM | iShares Russell 2000 ETF | 3.8% | 36 of 1,962 | 0.19% |
| QQQ | Invesco QQQ ETF | 3.3% | 6 of 101 | 0.17% |
| DIA | SPDR Dow Jones Industrial Average ETF | 1.6% | 1 of 30 | 0.16% |
| VTI | Vanguard Total Stock Market ETF | 1.4% | 57 of 2,941 | 0.03% |
| SPY | SPDR S&P 500 ETF | 1.2% | 7 of 502 | 0.09% |
| VXUS | Vanguard Total International Stock ETF | 0.0% | 1 of 8,035 | 0.05% |
Overlap = sum over shared holdings of the smaller of the two weights. 100% means identical portfolios.
About the BBP portfolio
Virtus LifeSci Biotech Products ETF holds 65 positions. The ten largest make up 27.5% of the fund and the top 50 85.3%, so it behaves like a portfolio of about 52 equally weighted stocks. The biggest positions are Moderna, Inc. (5.46%), Iovance Biotherapeutics, Inc. (4.47%), Verastem, Inc. (3.16%), Halozyme Therapeutics, Inc. (2.40%), Omeros Corporation (2.40%).
By sector, Healthcare is 97.8%, Technology is 1.4%. Holdings data is from the fund's latest portfolio as reported by EODHD on October 25, 2026; positions change as the fund rebalances.
Related: BBP chart, BBP performance, BBP overview.
BBP holdings FAQ
How many holdings does BBP have?
BBP holds 65 positions as of October 25, 2026.
What are the top 10 holdings of BBP?
The ten largest holdings are Moderna, Inc. (5.46%), Iovance Biotherapeutics, Inc. (4.47%), Verastem, Inc. (3.16%), Halozyme Therapeutics, Inc. (2.40%), Omeros Corporation (2.40%), Rigel Pharmaceuticals, Inc. (1.99%), BeiGene, Ltd. (1.96%), Kiniksa Pharmaceuticals, Ltd. (1.91%), Xeris Biopharma Holdings, Inc. (1.89%), Precigen, Inc. (1.86%). Together they are 27.5% of the fund.
What percentage of BBP is Moderna, Inc.?
Moderna, Inc. is the largest holding at 5.46% of net assets, about $7.1M of the fund's $129.9M.
How concentrated is BBP?
The top 10 holdings are 27.5% of the fund. By the effective number of holdings (1 divided by the sum of squared weights) BBP behaves like a portfolio of about 52 equally weighted stocks.